BioSpace News Archive

Health and Human Services Secretary Robert F. Kennedy Jr. speaks while President Donald Trump looks on

Vaccines

After Scrapping mRNA Contracts, Kennedy Says mRNA Vaccines ‘May Be Very Effective’ for Cancer

The Department of Health and Human Services’ mRNA pullback only applies to their use in upper respiratory disease, according to Secretary Robert F. Kennedy Jr.

August 15, 2025

·

2 min read

·

Tristan Manalac

Department of Homeland Security (DHS) Secretary Kristi Noem tours the National Biodefense Analysis and Countermeasures Cetner with Health and Human Services Secretary Robert F. Kennedy, Jr. and U.S. Senator Rand Paul on Fort Detrick, Maryland, June 16, 2025. (DHS photo by Tia Dufour)

Vaccines

Kennedy Revives Childhood Vaccines Safety Group, Led by NIH’s Bhattacharya

The move comes after Robert F. Kennedy Jr. received pressure from the Children’s Health Defense, an anti-vaccine non-profit that he co-founded, which last month sued him over his failure to run the “statutorily required Task Force on childhood vaccine,” according to the lawsuit.

August 15, 2025

·

2 min read

·

Tristan Manalac

The female hand is showing a thumbs-up gesture on a pink background, in an art collage. Positive hand sign. Fashion collage in the style of thumbs up magazine. Contemporary art. Modern design.

Approvals

Precigen Wins First FDA Immunotherapy Nod for Recurrent Respiratory Papillomatosis

Papzimeos is the first immunotherapy approved for recurrent respiratory papillomatosis, a rare lung disorder involving the development of benign tumors in the airways.

August 15, 2025

·

1 min read

·

Tristan Manalac

Job Trends

2025 Q2 Job Market Report: Quarterly Job Postings Decline for Third Straight Quarter

BioSpace data show biopharma professionals faced increased competition for fewer employment opportunities during the second quarter of 2025, with increased pressure from further layoffs.

August 15, 2025

·

4 min read

·

Angela Gabriel

Press Releases

Propanc Biopharma Announces Nasdaq Uplisting and Pricing of $4 Million Public Offering

August 15, 2025

·

4 min read

Press Releases

Retractable Technologies, Inc. Results for the Periods Ended June 30, 2025